NYSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/15/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNYSE
Market Capitalization10,983 mln
Earnings Date07/22/2026
EPS
0.54
Moderate
P / E
23.65
Premium valuation
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.55
Likely reliable
1-Year Forecast
14.32
Modest upside
Relative Strength
5
/ 100
Severely lagging
Business Description
Founded in 1984 and based in Hyderabad, India, Dr. Reddy's Laboratories is a global pharmaceutical company that develops, manufactures, and sells a wide range of medicines across markets including North America, Europe, Russia, and India. The company produces both branded and generic drugs for conditions spanning the heart, digestive system, skin, cancer, diabetes, and respiratory health, among others. It also supplies the raw chemical ingredients that other drug makers use to produce their own medicines, and invests in research to develop next-generation treatments in areas such as cancer and inflammation.
